BC Stock Analysis: Brunswick | NYSE
Recreational Vehicles | NYSE, USA | Market Cap: 5.357m USD | 12M Return: 33.2% | US1170431092 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 55.7M
EPS Trend: -90.7%
Qual. Beats: 2
Rev. Trend: -67.9%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Brunswick Corporation (NYSE: BC) is a global recreation products company headquartered in Mettawa, Illinois, and founded in 1845. It designs, manufactures, and markets a wide range of marine and recreational products across the United States, Europe, Asia-Pacific, Canada, and other international markets.
The company operates through four segments: Propulsion (outboard, sterndrive, and inboard engines under the Mercury family of brands), Engine P&A (aftermarket parts and consumables for marine and non-marine applications), Navico Group (marine electronics, sensors, power systems, and related accessories under brands such as Lowrance, Simrad, B&G, and Mastervolt), and Boat (fiberglass and aluminum boats under brands including Sea Ray, Boston Whaler, Lund, and Bayliner, along with the Freedom Boat Club).
Brunswick operates within the leisure products industry, a consumer discretionary segment that tends to track discretionary spending and economic cycles. Its business model spans the full marine value chain-from engine manufacturing and boat production to aftermarket parts distribution and electronics-giving it exposure to both OEM sales and recurring aftermarket revenue, as well as service-based offerings such as boat club memberships and dealer services.
- Mercury outboard share gains and pricing lift Propulsion margins
- Boat segment volumes hinge on consumer credit rates and discretionary spending
- Navico RV softness offsets marine electronics aftermarket growth
| Net Income: -86.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -2.64 > 1.0 |
| NWC/Revenue: 7.18% < 20% (prev 15.64%; Δ -8.46% < -1%) |
| CFO/TA 0.10 > 3% & CFO 524.8m > Net Income -86.0m |
| Net Debt (2.15b) to EBITDA (293.4m): 7.32 < 3 |
| Current Ratio: 1.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (65.5m) vs 12m ago -1.21% < -2% |
| Gross Margin: 25.35% > 18% (prev 23.85%; Δ 1.50% > 0.5%) |
| Asset Turnover: 99.65% > 50% (prev 87.97%; Δ 11.68% > 0%) |
| Interest Coverage Ratio: -0.04 > 6 (EBIT TTM -4.40m / Interest Expense TTM 101.4m) |
| A: 0.07 (Total Current Assets 2.07b - Total Current Liabilities 1.66b) / Total Assets 5.51b |
| B: 0.61 (Retained Earnings 3.36b / Total Assets 5.51b) |
| C: -0.00 (EBIT TTM -4.40m / Avg Total Assets 5.65b) |
| D: 0.41 (Book Value of Equity 1.60b / Total Liabilities 3.90b) |
| Altman-Z'' = 2.90 = A |
| DSRI: 0.99 (Receivables 559.3m/509.8m, Revenue 5.63b/5.10b) |
| GMI: 0.94 (GM 23.85% / 25.35%) |
| AQI: 0.97 (AQ_t 0.59 / AQ_t-1 0.60) |
| SGI: 1.10 (Revenue 5.63b / 5.10b) |
| TATA: -0.11 (NI -86.0m - CFO 524.8m) / TA 5.51b) |
| Beneish M = -3.04 (Cap -4..+1) = AA |
As of August 22, 2026, the stock is trading at USD 80.83 with a total of 437,923 shares traded. Over the past week, the price has changed by -1.70%, over one month by +0.84%, over three months by +3.21% and over the past year by +33.18%.
Current recommended Stop Loss: 75.80 (which is 6.2% or 1.8 ATR below the current price).
Brunswick has received a consensus analysts rating of 3.68. Therefore, it is recommended to hold BC.
- StrongBuy: 5
- Buy: 3
- Hold: 11
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 91 | 12.6% |
P/E Forward = 20.5339
P/S = 0.9515
P/B = 3.1046
P/EG = 0.7568
Revenue TTM = 5.63b USD
EBIT TTM = -4.40m USD
EBITDA TTM = 293.4m USD
Long Term Debt = 1.81b USD (from longTermDebt, last quarter)
Short Term Debt = 295.2m USD (from shortTermDebt, last quarter)
Debt = 2.44b USD (from shortLongTermDebtTotal, last quarter) + Leases 190.2m
Net Debt = 2.15b USD (calculated: Debt 2.44b - CCE 288.9m)
Enterprise Value = 7.50b USD (5.36b + Debt 2.44b - CCE 288.9m)
Interest Coverage Ratio = -0.04 (Ebit TTM -4.40m / Interest Expense TTM 101.4m)
EV/FCF = 21.88x (Enterprise Value 7.50b / FCF TTM 343.0m)
FCF Yield = 4.57% (FCF TTM 343.0m / Enterprise Value 7.50b)
FCF Margin = 6.09% (FCF TTM 343.0m / Revenue TTM 5.63b)
Net Margin = -1.53% (Net Income TTM -86.0m / Revenue TTM 5.63b)
Gross Margin = 25.35% ((Revenue TTM 5.63b - Cost of Revenue TTM 4.20b) / Revenue TTM)
Gross Margin QoQ = 28.10% (prev 24.93%)
Tobins Q-Ratio = 1.36 (Enterprise Value 7.50b / Total Assets 5.51b)
Interest Expense / Debt = 4.16% (Interest Expense 101.4m / Debt 2.44b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -3.48m (EBIT -4.40m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.24 (Total Current Assets 2.07b / Total Current Liabilities 1.66b)
Debt / Equity = 1.52 (Debt 2.44b / totalStockholderEquity, last quarter 1.60b)
Debt / EBITDA = 7.32 (Net Debt 2.15b / EBITDA 293.4m)
Debt / FCF = 6.26 (Net Debt 2.15b / FCF TTM 343.0m)
Total Stockholder Equity = 1.62b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.52% (Net Income -86.0m / Total Assets 5.51b)
RoE = -5.32% (Net Income TTM -86.0m / Total Stockholder Equity 1.62b)
RoCE = -0.13% (EBIT -4.40m / Capital Employed (Equity 1.62b + L.T.Debt 1.81b))
RoIC = -0.09% (negative operating profit) (NOPAT -3.48m / Invested Capital 3.86b)
WACC = 8.77% (E(5.36b)/V(7.79b) * Re(11.27%) + D(2.44b)/V(7.79b) * Rd(4.16%) * (1-Tc(0.21)))
Discount Rate = 11.27% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -91.28 | Cagr: -1.97%
[DCF] Terminal Value 71.52% ; FCFF base≈411.3m ; Y1≈360.7m ; Y5≈291.4m
[DCF] Fair Price = 34.31 (EV 4.37b - Net Debt 2.15b = Equity 2.22b / Shares 64.8m; r=8.77% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -90.66 | EPS CAGR: -34.86% | SUE: 2.40 | # QB: 2
Revenue Correlation: -67.92 | Revenue CAGR: -6.35% | SUE: 0.38 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.34 | Chg30d=-6.66% | Revisions=-69% | Analysts=18
EPS current Year (2026-12-31): EPS=4.56 | Chg30d=+6.70% | Revisions=+85% | GrowthEPS=+39.5% | GrowthRev=+7.7%
EPS next Year (2027-12-31): EPS=5.44 | Chg30d=+2.08% | Revisions=+53% | GrowthEPS=+19.2% | GrowthRev=+5.5%
[Analyst] Revisions Ratio: +33% (up=31, down=15)